Health-related quality of life in patients with psoriasis

Journal of Cutaneous Medicine and Surgery

Volumn 15, Issue 1, 2011, Pages 29-36

  Jankovic, Slavenka ^a   Raznatovic, Milena ^a   Marinkovic, Jelena ^a   Jankovic, Janko ^a   Kocev, Nikola ^a   Tomic Spiric, Vesna ^a   Vasiljevic, Nadja ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF EVALUATION; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; MONTENEGRO; PSORIASIS; QUALITY OF LIFE; SERBIA; YOUNG ADULT;

EID: 79951806753     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2010.10009     Document Type: Article

References (42)

1. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
2. Wahl A, Loge JH, Wiklund I, Hanestad BR. The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol 2000;4:803-8.
3. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-4.
4. de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol 2001;144 Suppl 58:33-6.
5. Sampogna F, Chren MM, Melchi CF, et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006;154:325-31. (Pubitemid 43382705)
6. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401-7. (Pubitemid 29418506)
7. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997;36:259-62. (Pubitemid 27242616)
8. Sampogna F, Gisondi P, Tabolli S, Abeni D. Impairment of sexual life in patients with psoriasis. Dermatology 2007;214:144-50. (Pubitemid 46377240)
9. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol 2006;54:420-6. (Pubitemid 43243444)
10. Javitz HS, Ward MM, Farber E, et al. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol 2002;46:850-60.
11. Sampogna F, Gisondi P, Melchi CF, et al. Prevalence of symptoms experienced by patients with different clinical type of psoriasis. Br J Dermatol 2004;151:594-9. (Pubitemid 39330883)
12. Sampogna F, Tabolli S, Soderfeldt B, et al. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006;154:844-9.
13. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venerol 1995;75:240-3.
14. Finlay AY, Kelly SE. Psoriasis-an index of disability. Clin Exp Dermatol 1987;12:8-11.
15. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433-40. (Pubitemid 27490569)
16. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for simple use. Clin Exp Dermatol 1994;19:210-6. (Pubitemid 24194579)
17. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
18. Fredricksson T, Petterson IN. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
19. Pivac-Marinkovic D. Quality of life of patients with inflammatory dermatoses and isolated skin lesions, measured by SKINDEX-29 questionnaire [Master's thesis]. Nis (Serbia): University of Nis; 2005.
20. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey manual and interpretation guide. Boston: New England Medical Center, The Health Institute; 1993.
21. Ware JE. SF-36 Health Survey update. Spine 2000;25:3130-9. (Pubitemid 32042945)
22. ProQolid Patient-Reported Outcome and Quality of Life Instruments Database SF-36 Health Survey Serbian version. Available at: http://www.proqolid. org/ (accessed July 20, 2008).
23. Steiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 2003.
24. Paykel ES. Methodological aspects of life events research. J Psychosom Res 1983;27:341-52. (Pubitemid 14207656)
25. Maslic SD, Vuletic G. Psychometric evaluation and establishing norms of Croatian SF-36 Health Survey: framework for subjective health research. Croat Med J 2006;47:95-102. (Pubitemid 43326907)
26. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51:1055-68. (Pubitemid 28527161)
27. Lundberg L, Johannesson M, Silverdahl M, et al. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000;80:430-4.
28. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. BMJ 1996;313:919-21. (Pubitemid 26340869)
29. Heydendael VM, deBorgie CA, Spuls PI, et al. The burden of psoriasis is not determined by disease severity only. J Investig Dermatol Symp Proc 2004;9:131-5. (Pubitemid 38457270)
30. Ware J, Kosinski M, Keller S. SF-36 physical and mental health summary scales. A user's manual. Boston: Health Assessment Laboratory; 1994.
31. McKenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol 1997;36:388-94. (Pubitemid 27131961)
32. Zachariae R, Zachariae C, Ibsen H, et al. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000;80:272-6.
33. de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a literature review. J Investig Dermatol Symp Proc 2004;9:140-7. (Pubitemid 38457272)
34. Touw CR, Hakkaart-van Roijen L, Verboom P, et al. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001;144:967-72.
35. Kent G, al-Abadie M. The psoriasis disability index - further analyses. Clin Exp Dermatol 1993;18:414-6.
36. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res 1997;42:467-75. (Pubitemid 27254621)
37. Sampogna F, Tabolli S, Mastroeni S, et al. Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology 2007;215:341-7. (Pubitemid 47519264)
38. Mrowietz U, Elder JT, Barker J. The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res 2006;298:309-19.
39. Sampogna F, Piccardi A, Chren MM, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004;66:620-4. (Pubitemid 38971260)
40. Feldman SR, Gottlieb AB, Bala M, et al. Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis. Br J Dermatol 2008;159:704-10.
41. Evers AW, Duller P, van de Kerkhof PC, et al. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol 2008;158:101-8. (Pubitemid 350225551)
42. Janković S, Raznatović M, Marinković J, et al. Relevance of psychosomatic factors in psoriasis: a case-control study. Acta Derm Venereol 2009;89:364-8.